21st Asia-Pacific Prostate Cancer Conference
Oceania/Australia AEST +10
14 October 2020
Sequencing and Selection of Therapy in Advanced Prostate Cancer
Session - Nursing & Allied Health, Clinical Urology, Translational Science - 120.0 mins - Room 01
The past decade has realised a plethora of positive phase III trials across the spectrum of advanced prostate cancer. Urologists, medical oncologists and radiation oncologists have an array of agents to choose from that have been proven to extend overall survival for men with advanced prostate cancer. This session will discuss how we can optimise the treatment of advanced prostate cancer and deliver better outcomes for our patients.
Join us for a Question and Answer session facilitated by our International Faculty - Professor Oliver Sartor and Melbourne based Medical Oncologist Associate Professor Arun Azad.
This session is proudly supported by Astellas
Treatment selection after AR Directed Therapy
Dr Arsha Anton - Walter and Eliza Hall Institute
New Treatment Approaches for mCRPC - Where do they fit in?
Dr Aneta Suder
Sequencing and Selecting Systemic Therapy: What roles do biomarkers play?
Dr Kate Mahon - Chris O’Brien Lifehouse
Join Prof Sartor and A/Prof Azad for a discussion with the speakers
Oliver Sartor, Arun Azad
Sequencing and Selection of Therapy in Advanced Prostate Cancer, Watch Wednesday Presentations on Demand, Live Question & Answer with our Nursing & Allied Health Experts
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Arsha Anton, Aneta Suder, Kate Mahon, Evie Mertens, Paul Hodges, Justin Chee, Gideon Blecher